Jeffrey A. Cohen

American neurologist

This biographical article is written like a résumé. Please help improve it by revising it to be neutral and encyclopedic. (April 2019)

|

Jeffrey A. Cohen

Born|  (1954-10-14) October 14, 1954 (age 70)
Scientific career
Institutions| Cleveland Clinic (Staff Neurologist)

Jeffrey Alan Cohen (born October 14, 1954) is an American neurologist specializing in multiple sclerosis and Director of Experimental Neurotherapeutics at the Cleveland Clinic Mellen Center for Multiple Sclerosis.

## Education

[edit]

This section of a biography of a living person does not include any references or sources. Please help by adding reliable sources. Contentious material about living people that is unsourced or poorly sourced must be removed immediately.
Find sources: "Jeffrey A. Cohen" – news · newspapers · books · scholar · JSTOR (April 2019) (Learn how and when to remove this message)

|

B.A. - Connecticut College, New London, Connecticut M.D. - University of Chicago Pritzker School of Medicine Chicago, Illinois Postdoctoral training - Neurology - University of Pennsylvania

## Notable contributions

[edit]

* Global Principal Investigator of the ACT (Avonex Combination Trial) clinical trial[1]
* Global Principal Investigator of the TRANSFORMS Phase III trial of Fingolimod, a novel oral agent for use in treating Multiple Sclerosis, the primary results of which were presented at the American Academy of Neurology Annual Meeting in May 2009.[2]
* Global Principal Investigator of the IMPACT trial, the first study to use the MS Functional Composite as the primary outcome measure in a clinical trial.[3]
* Co-Editor of the textbook "Multiple Sclerosis Therapeutics", ISBN 1841845256[4]
* Fellowship Director of the Mellen Center for MS National Multiple Sclerosis Society-supported Fellowship

## References

[edit]

1. ^ "ACT primary results manuscript".
2. ^ "Oral Fingolimod Superior to Interferon Beta1-a in RRMS". Medscape.
3. ^ "IMPACT primary results manuscript".
4. ^ Minkoff, Eli; Baker, Eli (March 6, 2007). Multiple Sclerosis Therapeutics. CRC Press. ISBN 9780203012055 - via Google Books.

## External links

[edit]

* articles by Jeffrey A. Cohen from PubMed

Authority control databases

International|

* ISNI
* VIAF
* WorldCat

National|

* Germany
* United States
* Poland
* Israel

Other|

* IdRef

This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it.

|

* v
* t
* e

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template